Rubric Capital Management (New York)’s Ovid Therapeutics OVID Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-478,533	Closed	-$158K	–	81
2025 Q2	$158K	Sell	478,533 -4,837,436	-91%	-$1.46M	﹤0.01%	66
2025 Q1	$1.66M	Hold	5,315,969	–	–	0.03%	63
2024 Q4	$4.96M	Hold	5,315,969	–	–	0.09%	64
2024 Q3	$6.27M	Hold	5,315,969	–	–	0.1%	56
2024 Q2	$4.09M	Hold	5,315,969	–	–	0.11%	63
2024 Q1	$16.2M	Hold	5,315,969	–	–	0.48%	50
2023 Q4	$17.1M	Sell	5,315,969 -129,941	-2%	-$444K	0.64%	41
2023 Q3	$20.9M	Hold	5,445,910	–	–	0.88%	34
2023 Q2	$17.9M	Sell	5,445,910 -1,555,214	-22%	-$5.28M	0.76%	38
2023 Q1	$18.1M	Buy	7,001,124 +173,059	+3%	+$410K	0.72%	45
2022 Q4	$12.7M	Buy	6,828,065 +2,311,765	+51%	+$3.94M	0.56%	49
2022 Q3	$8.31M	Buy	4,516,300 +1,633,594	+57%	+$3.42M	0.42%	52
2022 Q2	$6.2M	Buy	+2,882,706	New	+$6.97M	0.33%	55